Preformed Membrane-Associated Stores of Interleukin (Il)-12 Are a Previously Unrecognized Source of Bioactive IL-12 That Is Mobilized within Minutes of Contact with an Intracellular Parasite by Quinones, Marlon et al.
 
J. Exp. Med. 
 
Ó
 
 The Rockefeller University Press • 0022-1007/2000/08/507/09 $5.00
Volume 192, Number 4, August 21, 2000 507–515
http://www.jem.org/cgi/content/full/192/4/507
 
507
 
Preformed Membrane-associated Stores of Interleukin 
(IL)-12 Are a Previously Unrecognized Source of 
Bioactive IL-12 That Is Mobilized within Minutes 
of Contact with an Intracellular Parasite
 
By Marlon Quinones,
 
*
 
‡
 
 Sunil K. Ahuja,
 
*
 
‡
 
 Peter C. Melby,
 
*
 
‡
 
 Lyle Pate,
 
‡
 
 
Robert L. Reddick,
 
§
 
 and Seema S. Ahuja
 
*
 
‡
 
From the 
 
*
 
South Texas Veterans Health Care System, Audie L. Murphy Division, the 
 
‡
 
Department of 
Medicine, and the 
 
§
 
Department of Pathology, University of Texas Health Science Center at San 
Antonio, San Antonio, Texas 78229-3900
 
Abstract
 
The prevailing paradigm is that production of the interleukin (IL)-12 p70 heterodimer, a criti-
cal T helper cell type 1 (Th1)–inducing cytokine, depends on the induced transcription of the
p40 subunit. Concordant with this paradigm, we found that dendritic cells (DCs) produced IL-
12 p70 only after at least 2–4 h of stimulation with lipopolysaccharide plus interferon 
 
g
 
. How-
ever, using several complementary experimental approaches, including electron and confocal
microscopy, we now show that resting murine and human myeloid cells, including macro-
phages/DCs and DC-rich tissues, contain a novel source of bioactive IL-12 that is preformed and
membrane associated. These preformed, membrane-associated IL-12 p70 stores are released
within minutes after in vitro or in vivo contact with 
 
Leishmania
 
 
 
donovani
 
, an intracellular patho-
gen. Our findings highlight a novel source of bioactive IL-12 that is readily available for the
rapid initiation of Th1 host responses to pathogens such as 
 
Leishmania 
 
species.
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Introduction
 
IL-12 is central to the orchestration of both innate and ac-
quired immune responses (1). IL-12 is produced primarily
by phagocytic cells and, among its multiple activities, it is a
potent inducer of IFN-
 
g
 
 from T and NK cells (1). As such,
it is critical for the development of Th1 responses that are
required for generating protective cell-mediated inflamma-
tory responses against invading intracellular microorgan-
isms. The importance of IL-12 in generating protective
Th1 responses is illustrated by the finding that humans and
experimental murine models with genetic mutations that
block IL-12 or IFN-
 
g
 
–dependent signaling pathways have
marked sensitivity to intracellular infections such as the 
 
My-
cobacterium
 
 and 
 
Leishmania
 
 species (2–5).
There are two general paradigms regarding the mecha-
nisms that control IL-12 production by APCs such as den-
dritic cells (DCs)
 
1
 
 and macrophages. First, in all systems
where IL-12 regulation has been molecularly defined, it has
been found to be heavily transcriptionally dependent (1, 6,
7). Biologically active IL-12 (p70) is a heterodimeric pro-
tein composed of the covalently linked products of p40 and
p35, two separate genes that are regulated independently
(1). Although both p35 and p40 are highly regulated pro-
teins, there is general consensus that new synthesis of IL-12
p70 depends primarily on the induced transcription of the
p40 gene (1, 6–8). Notably, the induced transcription of
the p40 gene is delayed compared with other proinflamma-
tory cytokines such as TNF-
 
a
 
; stimulation of phagocytic
cells with LPS plus IFN-
 
g
 
 or 
 
Staphylococcus aureus
 
 (both po-
tent inducers of IL-12) leads to the accumulation of IL-12
 
p40 mRNA within 
 
z
 
2–4 h (1). Because the accumulation
of p40 mRNA occurs only after at least 2 h of APC activa-
tion, the general consensus is that bioactive IL-12 is avail-
able to induce Th1 differentiation only after this time pe-
riod (1).
A second emerging paradigm is that certain intracellular
pathogens may exploit a mechanism of IL-12 regulation
that involves cross-linking of surface receptors on macro-
phages (9). Through receptor-mediated mechanisms, micro-
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organisms such as the measles virus, HIV, and 
 
Leishmania ma-
jor 
 
have been shown to inhibit the production of IL-12,
whereas others, such as 
 
Mycobacterium tuberculosis
 
, 
 
Cryptococ-
cus neoformans
 
, and 
 
Toxoplasma gondii
 
, induce IL-12 produc-
tion (9–13). The basis for this differential host–microbe in-
teraction remains unclear. Nevertheless, the studies that have
examined the 
 
Leishmania
 
-mediated suppression of IL-12
production from APCs have generally been restricted to
the determination of IL-12 production after 2 h of contact
between the microbe and a distinct subset of APCs, namely
macrophages/monocytes (10–12).
DCs differ from monocytes/macrophages in their ability
to serve as potent activators of naive T cells, thus acting as
critical initiators of the primary specific immune response
(14). Given the central role of DC-derived IL-12 in induc-
ing Th1 differentiation and the notion that the factors that
influence Th1–Th2 skewing should be operative soon after
contact with a pathogen (14–18), we hypothesized that
there is a preformed store of IL-12 that is readily available
for the rapid initiation of a Th1 immune response shortly
after contact with specific microorganisms.
 
Materials and Methods
 
Materials.
 
All reagents for cell culture were obtained from
Life Technologies; recombinant growth factors were from R&D
Systems; ELISA reagents and antibodies were from PharMingen
and R&D Systems; and chemicals were from Sigma-Aldrich, un-
less stated otherwise.
 
Murine DCs.
 
DCs were differentiated from 4–6-wk-old mu-
rine (BALB/c) bone marrow cells in the presence of growth fac-
tors GM-CSF (50 ng/ml) and IL-4 (1 ng/ml) as previously de-
scribed (19). By FACS™ analysis, the cells had phenotypic
characteristics of DCs: they expressed abundant MHC class II,
CD80, CD40, CD11b, and DEC-205. Cell-surface markers for
contaminating macrophages (F4/80
 
1
 
), B cells (B220
 
1
 
), and T
cells (CD3
 
1
 
) were detected on 
 
, 
 
1% of cells.
 
Parasites.
 
6–70-d-old stationary phase 
 
Leishmania donovani
 
 1S
strain (MHOM/SD/001S-2D) were maintained in Medium 199
with 20% FBS and were washed three times in DMEM before
use. In some experiments, metacyclic promastigotes or op-
sonized/nonopsonized forms of 
 
L
 
.
 
 donovani
 
 and 
 
L
 
.
 
 major
 
 parasites
were also used (20, 21). Stationary-phase 
 
Leishmania
 
 promasti-
gotes were inactivated by exposure to UV light (12 h), formalin
(10% for 5 h), trypsin (1% for 5 h), or heat (65
 
8
 
C for 15 min). In
some experiments, parasites were treated with cytochalasin D (30
 
m
 
g/ml) for 1 h at 37°C; these parasites had reduced motility (due
to polymerization of the cell-wall actin; reference 22) but re-
mained viable (data not shown). In some experiments, stationary-
phase 
 
Leishmania
 
 promastigotes were labeled with the membrane-
stain PKH26 red fluorescent cell linker (Sigma-Aldrich). The
PKH-labeled promastigotes were fluorescent, viable in vitro, and
induced infection in vivo (data not shown).
 
DC Infection, Stimulation, or Treatment.
 
DCs were rested for
4 h before addition of 
 
L
 
. 
 
donovani
 
 promastigotes (10
 
7
 
/ml) or stim-
ulation with LPS (10 
 
m
 
g/ml) plus IFN-
 
g
 
 (20 U/ml). DCs (2–5 
 
3
 
10
 
6
 
/ml) were placed in polypropylene tubes, and live stationary-
phase 
 
L
 
.
 
 donovani
 
 promastigotes were added at a 10:1 multiplicity
of infection and mixed gently, then aliquots were transferred im-
mediately to 24-well plates and cultured at 37
 
8
 
C in 5% CO
 
2
 
. Du-
plicate wells were dedicated for each time point of analysis. At
 
various time intervals, the supernatants were harvested (duplicate
samples) and the IL-12 p70 levels were determined by ELISA
(anti–mouse IL-12 p35/p70 and p40/p70 were used as primary
and secondary antibodies, respectively). The detection range for
murine IL-12 p70 was between 12.3 pg/ml and 9,000 pg/ml. IL-
12 levels that fell below the limit of detection are designated as
zero (0). In some experiments, before addition of parasites or LPS
plus IFN-
 
g
 
, DCs were pretreated with monensin (2 
 
m
 
M for 4 h),
brefeldin A (1 
 
m
 
g/ml for 4 h), actinomycin D (10 
 
m
 
g for 1 h), or
cytochalasin D (10 
 
m
 
g for 1 h; all from Sigma-Aldrich). In some
experiments, opsonized or nonopsonized latex beads (2.97,
1.094, and 0.76 
 
m
 
m; Sigma-Aldrich) or 
 
Histoplasma capsulatum
 
G217 strain (23) were also added to the DCs. Methods for op-
sonization are as described in reference 21.
 
Bioassay.
 
To determine the biological activity of the pre-
formed stores of IL-12, the ability of IL-12 to induce Ag-specific
IFN-
 
g
 
 production was determined by a bioassay. Ag-primed
splenocytes were obtained from vaccinated or infected mice as
previously described (19). In brief, BALB/c mice were vaccinated
intravenously with bone marrow–derived DCs pulsed with solu-
ble 
 
L
 
.
 
 donovani–
 
derived Ag. 14 d later, the spleens were har-
vested, and single-cell suspensions (10
 
6
 
/ml) were used in the bio-
assay. The splenocytes were cultured with Ag, i.e., soluble 
 
L
 
.
 
donovani–
 
derived Ag (25 
 
m
 
g/ml) 
 
6 
 
sample supernatants (50%
vol/vol of supernatants of DCs alone or DCs that had been in
contact with 
 
L
 
.
 
 donovani
 
 for 10 min) 
 
6 
 
recombinant IL-12 p70 or
IL-12–blocking antibody (clone 17.8). At the concentration used
(4 
 
m
 
g/ml), the IL-12 blocking antibody blocks IL-12–induced
IFN-
 
g
 
 production by 50%. IFN-
 
g
 
 was measured by ELISA after
48 h of addition of the DC supernatants to the splenocytes.
 
DC Labeling and Confocal Microscopy.
 
DCs were labeled with
the indicated antibodies at 4°C or room temperature with or
without cell permeabilization. A commercially available anti–IL-
12 p70 Ab (R&D Systems) was used to localize IL-12 p70 with
rat anti–mouse IL-12 p70 IgG1 followed by FITC-conjugated
mouse anti–rat IgG1. Nonspecific binding was blocked using 5%
mouse serum or 10% fetal bovine serum. As control for IL-12
p70, the biotinylated rat anti–mouse IgG1 isotype standard plus
mouse anti–rat IgG1-FITC was used. Saponin (0.1%) solution
was used to permeabilize cells. Labeled DCs were analyzed on an
Olympus-Fluoview confocal laser scanning microscope (480-
argon laser and 568-krypton laser).
 
Electron Microscopy.
 
All steps were performed on ice and each
wash was repeated three times with TBS (pH 7.6), unless indi-
cated otherwise. Murine DCs were cultured in 24-well plates,
supernatants were removed, and the adherent cells were washed,
incubated with primary (anti–IL-12 p70) or isotype control Ab
(rat IgG1) for 1 h, washed again, and then incubated with sec-
ondary Ab (biotinylated anti-IgG1) for 1 h. DCs were washed,
incubated with streptavidin 10-nm gold particles (PharMingen)
for 1 h, washed again, and fixed with electron microscopy (EM)
fixative for 15 min (2% paraformaldehyde/0.5% glutaraldehyde)
and then with 1% osmium tetroxide for 30 min, and then rinsed
with veronal-acetate buffer. To dehydrate the cells, a graded se-
ries of ethanol (10 min incubation at each increasing concentra-
tion) followed by a mixture of absolute ethanol and Polybed 812
resin (15 min) was used. The DCs were covered with resin for 15
min; after draining the resin, resin-filled Beem capsules were
placed over the cells and incubated at 58
 
8
 
C overnight. The poly-
merized resin capsules with adherent DCs were removed from
the plate and incubated at 85
 
8
 
C for 1 h. Thin sections were cut
from each block, stained with uranyl acetate and lead citrate, and
viewed using a Phillips electron microscope. 
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DC Lysates.
 
Murine DCs (10
 
7
 
) were resuspended in com-
plete lysis buffer composed of 700 
 
m
 
l of 1
 
3
 
 Relaxation buffer-
EGTA (1,000 mM KCL, 30 mM NaCl, 35 mM MgCl
 
2
 
, 10 mM
ATP[NA]
 
2
 
, 12.5 mM EGTA, 100 mM Pipes, pH 6.8; reference
24) prepared in distilled water, 100 
 
m
 
l of 1 mg/ml leupeptin, 100
 
m
 
l of 1 mg/ml of pepstatin (all Sigma-Aldrich), 100 
 
m
 
l of 5%
NP-40 (Polysciences), and 10 
 
m
 
l of 100 mM PMSF (Sigma-
Aldrich) in isopropanol. The DC lysates were centrifuged at 2,200
rpm at 4
 
8
 
C. Supernatants were collected and used in an ELISA
for IL-12 p70.
 
DC Plasma Membrane Extraction.
 
The methods of Maeda et
al. (25) were used to isolate plasma membranes from 5 
 
3
 
 10
 
7
 
bone marrow–derived DCs. In brief, DCs were resuspended in 5
ml of the homogenization buffer described by Maeda et al. and
homogenized using a Polytron homogenizer (Ika Labortechnics).
The homogenate was layered over 10 ml of 41% sucrose in the
homogenization buffer and centrifuged at 95,000 
 
g
 
 for 1 h in a
Beckman TL-100 ultracentrifuge. The white band at the inter-
face was collected, centrifuged, washed, and resuspended in the
complete lysis buffer described above and then used as the plasma
membrane fraction (25). After sucrose gradient centrifugation, the
pellet below the interface was used as the nonplasma membrane
fraction (25).
 
Protein Extraction from Tissues.
 
Mouse and human spleens,
thymus, and lymph nodes, and mouse ears were homogenized.
Ears from BALB/c mice were dissected, the dermal and epider-
mal sheets were separated and cut into small pieces with scissors,
and the pieces were then homogenized between the frosted ends
of two microscope slides. The homogenized ear tissue was soni-
cated for 15 s on ice and rested for 1–2 min on ice, and the soni-
cation was repeated three more times. Single-cell suspensions
were prepared from mouse spleen, thymus, and lymph nodes by
homogenizing the tissue between the frosted ends of two micro-
scope slides. Erythrocytes in these cell suspensions were lysed
with red cell lysis buffer (Sigma-Aldrich); the cell pellet was
washed twice with PBS and then resuspended in 500 
 
m
 
l of com-
plete lysis buffer (described above). The cell lysates from the
aforementioned tissues were centrifuged at 2,200 rpm at 4
 
8
 
C, and
an ELISA was used to measure IL-12 p70 in these supernatants.
Frozen human tissues (courtesy of Dr. D. Troyer, Pathology
Core of the San Antonio Cancer Institute, San Antonio, TX)
were homogenized and resuspended in the complete lysis buffer
and centrifuged, and IL-12 p70 levels in the supernatants were
measured by ELISA. All of the aforementioned procedures were
conducted at 4
 
8
 
C or on ice.
 
Human Leukocyte Isolation and Cell Lysates.
 
Leukocytes were
isolated from 50 ml of heparinized venous blood obtained from
normal volunteers. Equal volumes of blood and a solution con-
taining 3% dextran (Amersham Pharmacia Biotech) and 0.85%
NaCl were mixed, and erythrocytes were sedimented for 18 min
at 4
 
8
 
C, followed by centrifugation at 1,800 rpm for 5 min at 4
 
8
 
C.
Osmotic lysis (at 4
 
8
 
C) was used to remove the remainder of the
erythrocytes. The leukocyte pellet was washed two times with
cold PBS and then resuspended in 500 
 
m
 
l of complete lysis buffer.
The cell lysates were centrifuged at 2,200 rpm at 4
 
8
 
C, and IL-12
p70 was measured in the supernatants. PBMCs and neutrophils
were prepared as described previously (26). PBMCs were resus-
pended in RPMI and 10% FBS and cultured in tissue culture
flasks for 2 h. The nonadherent cells (lymphocyte fraction) were
aspirated and the adherent cells (monocytes) were collected using
cell scrapers.
 
Animals and Infection. L
 
.
 
 donovani 
 
promastigotes (2–3 
 
3
 
 107/2
ml of PBS) were injected into the peritoneal cavity of 6-wk-old
BALB/c mice. After 20 min, the peritoneal fluid was removed,
the cells were pelleted by centrifugation at 2,200 rpm for 5 min,
and the supernatants were snap frozen and stored at 2708C until
measurement of IL-12 p70. The local review boards of the Uni-
versity of Texas Health Science Center at San Antonio approved
all protocols.
Results
Preformed, Membrane-associated IL-12 p70. Based on the
homology between the IL-12 p40 subunit and the extracel-
lular domain of the IL-6 receptor as well as the finding that
p35 encodes an NH2-terminal sequence resembling that
found in some membrane-associated proteins, a theoretical
argument was made for a membrane-bound p70-like com-
plex that could initiate responses on cell–cell contact (27).
Using a heterodimer-specific anti–IL-12 mAb, Fan et al.
(28) provided flow cytometry evidence suggestive of IL-12
on the cell surface of a human monocytic and a murine
macrophage cell line. However, direct evidence for a func-
tional membrane-associated, preformed pool of IL-12 is
lacking. Given the central role of the DC–IL-12 axis in
host immune functions, our initial efforts were focused on
determining whether there is a membrane-associated form
of IL-12 p70 in this cell type.
By confocal microscopy, IL-12 p70 immunoreactivity
was localized to the periphery of nonpermeabilized DCs
(Fig. 1, A and B). By FACS™ analysis, 70% of the identical
population of DCs used for confocal microscopy stained for
IL-12 p70 (Fig. 1 C), and after permeabilization there was
no increase in fluorescence intensity of IL-12 p70 and only a
4–6% increase in the number of positive-staining cells (data
not shown). The immunoreactivity for IL-12 p70 colocal-
ized with that for intercellular adhesion molecule (ICAM)-1,
a well-characterized plasma membrane–associated molecule
(29, 30; Fig. 1, D–F). In additional experiments, immunore-
activity for IL-12 p40 or p35 was also detected on the pe-
riphery of nonpermeabilized DCs (data not shown).
The peripheral localization of immunoreactive IL-12
p70 on DCs was confirmed by EM studies (Fig. 2, A and
B). Immunogold reactivity for IL-12 p70 but not the iso-
type control was present along the entire surface of the DC
plasma membrane. The p40 subunit of the IL-12 was also
detected on the cell surface by EM (data not shown).
We also used cell fractionation of permeabilized and
nonpermeabilized cells to determine the distribution of IL-
12 p70 in the plasma membrane and nonplasma membrane
fractions of murine DCs. Based on both biochemical and
immunologic criteria, plasma membranes prepared by the
methods of Maeda et al. yield high-purity plasma mem-
brane fractions (25). Using this method for cell fraction-
ation in three separate experiments, we found that the ratio
of the IL-12 p70 content in DC plasma membranes/non-
plasma membranes was generally 5:1. For example, in a
typical experiment, the IL-12 p70 content in the plasma
membrane fraction was 50 pg/mg of protein, whereas in
the nonplasma membrane fraction it was 11 pg/mg of pro-
tein. In the absence of NP-40 in the complete lysis buffer,510 Preformed Stores of Bioactive IL-12
IL-12 p70 was not detected in any of the samples exam-
ined. Thus, these data complement the microscopic studies
(Figs. 1 and 2), and collectively indicate that the bulk of the
preformed stores of IL-12 p70 in unstimulated DCs is re-
stricted primarily to the plasma membrane.
Biological Relevance of Preformed, Membrane-associated Stores
of IL-12 p70. Given the importance of IL-12 in mediat-
ing rapid host responses to invading organisms, we asked
the following questions: is this membrane-associated im-
munoreactive IL-12 p70 released from the cell surface, and
is it biologically active? We also surmised that in the con-
text of host–parasite interactions, such as that between L.
donovani, an intracellular parasite, and DCs, this source of
preformed IL-12 should be available to initiate host im-
mune responses soon after contact with the parasite. For
this reason, we limited our analyses to determining the bio-
Figure 1. Plasma membrane
localization of immunoreactive
IL-12 p70 on resting nonperme-
abilized murine DCs. DCs were
stained with IL-12 p70 (A) or rat
IgG1 isotype Ab (B) and visual-
ized by confocal microscopy. (C)
FACS™ analysis showing that
z70% of the DC population
shown in A has surface staining
for IL-12 p70. (D–F) Fluores-
cence for IL-12 p70-FITC (D,
green), ICAM-1-PE (E, red), or
colocalization of IL-12 p70 and
ICAM-1 (F, orange). One repre-
sentative experiment out of three
is shown.
Figure 2. EM photomicrographs showing plasma membrane localization of IL-12 p70 (arrows) in DCs. DCs were labeled with IL-12 p70 (A) and iso-
type control Ab (B) and visualized by EM. One representative experiment out of three is shown.511 Quinones et al.
availability of this source of IL-12 shortly after DCs come
into contact with L. donovani.
The IL-12 p70 produced by unstimulated DCs was be-
low the detection limits of the ELISA; however, after as lit-
tle as 10 min of contact with stationary phase (or purified
metacyclic) L. donovani promastigotes, murine DCs released
IL-12 p70 (Fig. 3 A). This release was independent of de
novo IL-12 synthesis, as pretreatment of DCs with actino-
mycin D (inhibitor of transcription) or monensin or brefel-
din A (inhibitors of Golgi transport) had no effect on the
amounts of IL-12 p70 released from DCs (Fig. 3 A).
In contrast to these effects of L. donovani, there was no
detectable IL-12 p70 in the DC supernatants stimulated for
10 min with LPS plus IFN-g (Fig. 3 A). However, consis-
tent with the time required to induce IL-12 p40 transcrip-
tion (1, 6, 7), the release of IL-12 p70 from DCs after stim-
ulation with LPS plus IFN-g was detected only after 2–4 h
(z100–300 pg/ml), and this was inhibited by pretreatment
of DCs with actinomycin D, monensin, or brefeldin A
(data not shown).
Although the ELISA used to measure the IL-12 released
from DCs detects the bioactive form for IL-12 p70, we
used a bioassay to confirm this (Fig. 3 B). Addition of su-
pernatants from DCs in contact with L. donovani increased
the production of IFN-g from Ag-primed splenocytes, and
this increase was partially inhibited by an IL-12–blocking
Ab (Fig. 3 B). The increase in IFN-g that occurred after
addition of supernatants from DC–parasite cocultures was
similar in magnitude to that observed after addition of rIL-
12 p70 to splenocytes. Collectively, these findings indicate
that biologically active levels of IL-12 p70 were present in
the supernatants of DC–L. donovani cocultures.
We next postulated that if the parasites indeed trigger the
rapid release of membrane-associated IL-12, then the pe-
ripherally localized immunoreactivity for IL-12 p70 should
diminish shortly after DCs come into contact with L. dono-
vani. Concordant with this, membrane-bound immunore-
activity for IL-12 p70 was detected before (Fig. 4 A) and
immediately after (Fig. 4 B) addition of L. donovani promas-
tigotes but not after 10 or 30 min (Fig. 4 C) of contact be-
tween DCs and parasites. The timing at which this com-
plete loss of immunoreactivity occurred depended on the
temperature at which DCs had been labeled. For DCs la-
beled at room temperature it was after 10 min of contact
with parasites (data not shown), whereas for DCs labeled at
48C the loss was partial at 10 min but complete at 30 min
(Fig. 4, A–C). In contrast, there was no loss in IL-12 p70
immunoreactivity in DCs that had been stimulated with
LPS plus IFN-g for 10 min, nor if the DCs were exposed
to L. donovani parasites pretreated with cytochalasin D (data
not shown).
Concomitant with this loss in the membrane-bound im-
munoreactivity for IL-12 p70 (Fig. 4, A–C), there should
be a corresponding decrease in the total content of IL-12
p70 in DCs that were in contact with parasites. Fig. 4 D
shows that the IL-12 p70 content in the lysates of DCs that
were in contact with parasites was significantly lower than
in unstimulated DCs. The converse was observed in the su-
pernatants of these DC cultures: the levels of IL-12 p70
were significantly higher in the supernatants of DC–Leish-
mania cocultures than in unstimulated DCs (Fig. 4 D).
Taken together, the confocal microscopy findings and the
pattern of IL-12 content in the supernatants and DC lysates
before and after addition of parasites is consistent with the
presence of a preformed pool of membrane-associated IL-
12 p70 that is biologically active and is readily released after
contact with L. donovani.
To extend these findings, observed in an in vitro setting
of DC–parasite contact, we determined whether IL-12 p70
is released rapidly in vivo in response to an infectious chal-
lenge. In this in vivo model, L. donovani promastigotes or
PBS was introduced into the peritoneal cavity of BALB/c
mice and the peritoneal fluid was recovered after 20 min.
IL-12 p70 could be detected in the fluid recovered from
the peritoneal cavity of mice after a challenge with L. dono-
vani promastigotes (Fig. 4 E), but not in the peritoneal fluid
collected after the injection of PBS. In contrast, the
amounts of IL-12 p70 in the cell lysates of cells collected
Figure 3. Rapid release of bioactive, preformed IL-12 p70 after 10 min of contact with L. donovani (Ld) promastigotes. (A) IL-12 p70 was detected in
the supernatants of DCs in contact with L. donovani for 10 min but not in the supernatants of DCs stimulated for the same duration with LPS plus IFN-g.
Pretreating (pretreat) DCs with actinomycin (Act), brefeldin A (Bref), or monensin (Mon) had no effect on the amounts of IL-12 p70 released from
DCs in contact with L. donovani. (B) Supernatants (Sup) from unstimulated DCs or DCs in contact with L. donovani (DC 1 Ld) was added to Ag-reactive
splenocytes (Spl). A blocking IL-12 Ab but not isotype control Ab reduced the amounts of IFN-g that is released after addition of supernatants from DC–
Leishmania cocultures to Ag-reactive splenocytes. The amounts of IFN-g released from splenocytes after addition of supernatants from DC–Leishmania
cocultures to Ag-reactive splenocytes was similar to that released after addition of recombinant IL-12 p70 (300 pg/ml).512 Preformed Stores of Bioactive IL-12
from the peritoneal cavity after PBS challenge was higher
than that found in the cell lysates of cells collected after the
parasite challenge. These in vivo findings mirrored the in
vitro findings shown in Fig. 4, A–D. Because macrophages
and not DCs are the more common cell type in the perito-
neal cavity, it is likely that these APCs are the major con-
tributor of the preformed IL-12 detected.
In Vitro Determinants of IL-12 p70 Release. What are
the  L. donovani determinants that contribute to the rapid
release of bioactive IL-12? Is contact with the parasite suffi-
cient, or is phagocytosis required for IL-12 release? Does
contact with innate objects or nonmotile organisms also in-
duce the release of IL-12? To address these questions, we
conducted a series of experiments (Fig. 5). Parasites inacti-
vated by heat or other inactivating agents (UV light, for-
malin, or trypsin), Histoplasma capsulatum (an intracellular
nonmotile fungal organism), or latex beads of varying di-
ameters, did not induce the release of IL-12 p70 from DCs.
Infection with Leishmania involves two processes: parasite-
dependent attachment and host-dependent internalization,
and pretreatment of Leishmania promastigotes with cyto-
chalasin is known to reduce significantly the ability of the
parasites to attach to cells (22). We found that Leishmania
promastigotes immobilized (but not killed) with cytochala-
sin D did not induce IL-12 release (Fig. 5 A). In contrast,
pretreatment of DCs with cytochalasin D, an inhibitor of
phagocytosis, reduced DC infection by 50% but did not in-
hibit IL-12 p70 release from DCs in contact with Leishma-
nia species. Furthermore, phagocytosed intracellular para-
sites were only visualized after 30 min (Fig. 5 B), but not
after 10 min of contact with DCs (Fig. 5 C). Collectively,
these findings indicated that an important determinant for
the very early release of preformed membrane-associated
DC stores of IL-12 is contact with motile live L. donovani
parasites but not phagocytosis.
Distribution of Preformed IL-12 p70 in Murine and Human
Leukocytes and Tissues. We next determined whether this
preformed membrane-associated IL-12 p70 was specific to
murine DCs/macrophages or were they also present in
other murine and human cells/tissues. As described in Ma-
terials and Methods, special care was taken to avoid stimu-
lating the cells while processing these samples. IL-12 p70
(pg/mg of protein; mean 6 SD; n 5 12 mice) was present
in the cell lysates of skin (4.0 6 2.8), lymph node (4.9 6
Figure 4. Contact between DCs and L.
donovani (Ld) promastigotes leads to a
rapid decrease in the membrane-associated
immunoreactivity for IL-12 p70. (A)
Resting nonpermeabilized DCs were
stained for IL-12 p70 at 48C. Using con-
focal microscopy, the IL-12 p70–labeled
green fluorescent cells were visualized in
unstimulated nonpermeabilized DCs (t 5
0 min). (B) PKH-labeled red fluorescent
parasites were added after 1 min (t 5 1
min). (C) Loss of green fluorescence, i.e.,
IL-12 p70 immunoreactivity was not ob-
served after 30 min of contact with para-
sites (t  5 30 min). Note that the same
field is being visualized in A–C. One rep-
resentative experiment out of three is
shown. (D) Inverse relationship between
the amount of plasma membrane–bound
IL-12 p70 and the amount of IL-12 p70
released into the supernatant after DC–
parasite contact in vitro. The amount of
membrane-bound IL-12 p70 was lower in
the lysates of DCs in contact with the par-
asite compared with lysates from unstimu-
lated DCs. In contrast, the amounts of IL-
12 p70 in the supernatants (Sups) from
DC–Leishmania cocultures was higher
than that in supernatants of resting DCs.
One representative experiment out of
three is shown. (E) L. donovani promasti-
gotes induced the rapid in vivo release of
IL-12. L. donovani stationary phase (2–3 3
107/2 ml of PBS) or PBS was injected
into the peritoneal cavity of BALB/c
mice, and after 20 min the peritoneal fluid
was collected and centrifuged. IL-12 p70
in the supernatants and the lysates of the
cell pellet was determined. The amount of IL-12 p70 in peritoneal fluid of mice injected with PBS was low, whereas that present in the peritoneal cell
pellet lysates was high. In contrast, in mice injected with L. donovani, the amount of IL-12 p70 in the peritoneal fluid was high, whereas that present in
the peritoneal cell pellet lysates was low. The experiment was performed three times (n 5 four mice/group), with similar results.513 Quinones et al.
1.3), spleen (2.6 6 0.4), and thymus (3.8 6 1.6) of BALB/c
mice; the cell lysates from RAW and J774 murine cell lines
also contained IL-12 p70.
Preformed IL-12 p70 was also present in the cell lysates
of several human tissues including lymph nodes, spleen,
and thymus, and myeloid cells such as monocytes and gran-
ulocytes (Fig. 6). Notably, there was a wide interindividual
variation in the amounts of preformed IL-12 p70 present in
the total leukocyte population (Fig. 6).
Discussion
In support of our hypothesis, we discovered a bioactive
IL-12 p70 in myeloid cells, including DCs that are readily
available for rapid release after contact with an intracellular
parasite such as L. donovani. This readily mobilizable source
of IL-12 is independent of the induced transcription of IL-
12 p40 and is membrane associated. IL-12 p70 represents
the covalent association between p40 and p35, and hence
the finding of p70 in the plasma membranes of unstimu-
lated, native phagocytes would suggest a preassembled store
of this cytokine.
The complete repertoire of microbial agents and the pre-
cise microbe- or host-dependent factors that trigger the
rapid release of membrane-associated preformed IL-12 are
not known. In addition to the data presented here for L.
donovani, L. major and Listeria monocytogenes—highly motile
microorganisms—also induced the early release of IL-12
p70 from splenocytes and DCs after 10 min of contact (data
not shown). We found that as early as 10 min after DC–L.
donovani contact, NF-kb proteins were translocated (data
not shown), but whether this signaling cascade initiated af-
ter cell contact is required for the rapid release of pre-
formed IL-12 stores is currently under investigation.
Our studies provide a mechanism for the observation
that IL-12 is released rapidly from DCs after in vivo infec-
tion with L. major (31) or L. donovani (10), and perhaps
other organisms such as Toxoplasma (13). Our in vitro and
in vivo studies would also suggest that preformed stores of
bioactive IL-12 are also available for rapid release from
monocytes and macrophages. The rapid release of these IL-
12 stores appears to be dependent on contact between DCs
and parasites but independent of phagocytosis. Based on
studies by other investigators, there is evidence that once
the parasite is internalized, the transcription-dependent
synthesis of IL-12, at least in monocytes/macrophages, is
impaired (10–12).
Given the central role of IL-12 in host defenses, the
swiftness with which preformed bioactive IL-12 was mobi-
lized after DC–parasite contact should not be surprising. It
is striking that evolutionarily conserved systems are also in
place for the rapid release via preformed stores of other
proinflammatory cytokines such as TNF-a (32, 33). It is
conceivable that the rapid release of IL-12 from DCs may
act in an autocrine fashion to further stimulate DCs via
constitutively expressed IL-12 receptors (34), and/or serve
Figure 5. Determinants of the IL-12 p70
release by DCs. (A) 10 min after adding infec-
tious or noninfectious agents to resting or cy-
tochalasin D–-pretreated murine DCs, IL-12
p70 was measured in the supernatants of DCs
by ELISA. *, L. donovani inactivated by differ-
ent methods; §, opsonized or nonopsonized
latex beads or H. capsulatum. The findings
were similar with opsonized and nonop-
sonized latex beads, and were also the same
regardless of the method used to inactivate the
parasites (see Materials and Methods), and for
this reason a single bar is used to represent
these findings. †, DCs pretreated with cy-
tochalasin D for 1 h and then cocultured with
L. donovani; ‡, L. donovani pretreated with cy-
tochalasin D (Cyto) for 1 h and then added to
the DCs. Brackets indicate pretreatment of
DCs or parasites with cytochalasin D. Results
are from one of three representative experiments. (B–C) The PKH26 red fluorescent cell linker kit was used to label L. donovani parasites. DCs were
stained with FITC. The interaction between labeled parasites (red) and the DCs (green) was visualized at different time points. After 30 min (B) parasites
were found within some DCs, whereas they were still extracellular at 10 min (C). Data from one of three representative experiments is shown.
Figure 6. Distribution of IL-12 p70 in human cells/tissues. IL-12 p70 (in
pg) detected in protein lysates of total leukocytes (Lu) isolated from whole
blood (values normalized to pg/ml of blood); neutrophils (N), lymphocytes
(Ly), or monocytes (Mo) (values normalized to pg/106 cells); lymph node
(LN), spleen (Sp), or thymus (Th) (values normalized to pg/g tissue). Note
that the scales of the left and right y axes are different and are for the values
to the left and right, respectively, of the tick marks on the x axis.514 Preformed Stores of Bioactive IL-12
as a first line of defense by activating T cells or NK cells in
the immediate vicinity (35). In this scenario, the immediate
release of even low levels of membrane-associated IL-12
could trigger a host of critical immune responses, including
upregulation of the IL-12 receptor (36) and a consequent
increase in cell responsiveness to IL-12, and the induction
of an early IFN-g response. This is highly relevant in the
context that immunity against intracellular protozoan Leish-
mania species is highly dependent on the rapid development
of a Th1-biased immune response (17, 37). Indeed, the
very rapid release of bioactive IL-12 after parasite–DC con-
tact is consistent with the hypothesis that IL-12 serves as a
“match” to ignite the immune response in L. major infec-
tion (38). Furthermore, several studies using recombinant
IL-12 and anti–IL-12 antibody have documented that the
early IL-12 response to infection is critical to the final out-
come (39, 40). Whether the amounts of preformed mem-
brane-associated IL-12 in humans are genetically controlled
remains to be established, but variability in the amounts
stored and/or released could be an important determinant
of host susceptibility to various infections.
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